Hosted on MSN1mon
Stifel maintains $28 target on Phathom Pharmaceuticals stockFriday - Stifel analysts have maintained a Buy rating ... is optimistic that Voquezna, in its bottle format, will be granted the same 10-year exclusivity currently enjoyed by the combo packs ...
ST. LOUIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth Tracker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results